1-4 of 4
Yasushi Kasahara
Close
Sort by
Journal Articles

A Novel Method for Highly Efficient Ex Vivo Expansion and Genetic Engineering of Human Natural Killer Cells for Cancer Therapy

Nobuhiro Kubo, Yudai Murayama, Yasushi Kasahara, Chansu Shin, Minori Baba, Ryosuke Hosokai, Haruko Iwabuchi, Imamura Masaru, Akihiko Saitoh, Chihaya Imai
Journal: Blood
Blood (2021) 138 (Supplement 1): 2850.
https://doi.org/10.1182/blood-2021-152356
Published: 2021
Journal Articles

A Novel NKp44-Based Chimeric Antigen Receptor That Targets Multiple Types of Cancer

Yasushi Kasahara, MD, Changsu Shin, MD, Sakiko Yoshida, MD PhD, Takayuki Takachi, MD PhD, Nobuhiro Kubo, MD, Haruko Iwabuchi, MD PhD, Masaru Imamura, MD PhD, Akihiko Saitoh, MD PhD, Chihaya Imai, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3517.
https://doi.org/10.1182/blood.V128.22.3517.3517
Published: 2016
Journal Articles

Interleukin-21 Gene Transduction in Human Natural Killer Cells Enhances Their Anti-Leukemic Capacity

Yasushi Kasahara, MD, Changsu Shin, MD, Takayuki Takachi, MD PhD, Haruko Iwabuchi, MD PhD, Masaru Imamura, MD PhD, Akihiko Saitoh, MD PhD, Chihaya Imai, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5425.
https://doi.org/10.1182/blood.V126.23.5425.5425
Published: 2015
Journal Articles

Simultaneous Use of Histone Deacetylase Inhibitor Valproic Acid Potentiates Natural Killer Cell Cytotoxicity against T-Lineage Acute Lymphoblastic Leukemia

Takayuki Takachi, MD, Chihaya Imai, MD, PhD, Yasushi Kasahara, MD, Masaru Imamura, MD, PhD, Makoto Uchiyama, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 5438.
https://doi.org/10.1182/blood.V112.11.5438.5438
Published: 2008